Ramnath, N <br/><br/>
S-phase modulation by irinotecan: pilot studies in advanced solid tumors.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Nov 2005 
 - 447-54 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/s00280-004-0951-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biopsy<br/>Camptothecin--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cyclin A--analysis<br/>Deoxycytidine--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Gastrointestinal Neoplasms--drug therapy<br/>Humans<br/>Irinotecan<br/>Male<br/>Maximum Tolerated Dose<br/>Respiratory Tract Neoplasms--drug therapy<br/>S Phase--drug effects<br/>Gemcitabine